nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLC7A5—Melphalan—hematologic cancer	0.208	0.386	CbGbCtD
Levothyroxine—ALB—hematologic cancer	0.0791	0.512	CbGaD
Levothyroxine—ABCB1—hematologic cancer	0.0755	0.488	CbGaD
Levothyroxine—SLCO1A2—Chlorambucil—hematologic cancer	0.0314	0.0585	CbGbCtD
Levothyroxine—SLCO4C1—Methotrexate—hematologic cancer	0.0232	0.0433	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—hematologic cancer	0.0163	0.0304	CbGbCtD
Levothyroxine—SLCO1A2—Prednisolone—hematologic cancer	0.0119	0.0221	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—hematologic cancer	0.0112	0.0209	CbGbCtD
Levothyroxine—ABCB1—Lenalidomide—hematologic cancer	0.0102	0.0191	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—hematologic cancer	0.01	0.0187	CbGbCtD
Levothyroxine—CYP2C8—Bortezomib—hematologic cancer	0.00928	0.0173	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—hematologic cancer	0.00911	0.017	CbGbCtD
Levothyroxine—ALB—Imatinib—hematologic cancer	0.00879	0.0164	CbGbCtD
Levothyroxine—CYP2C8—Ifosfamide—hematologic cancer	0.00711	0.0132	CbGbCtD
Levothyroxine—SLCO1A2—Dexamethasone—hematologic cancer	0.007	0.013	CbGbCtD
Levothyroxine—CYP2C8—Nilotinib—hematologic cancer	0.00618	0.0115	CbGbCtD
Levothyroxine—CYP3A4—Bexarotene—hematologic cancer	0.00614	0.0114	CbGbCtD
Levothyroxine—ABCB1—Daunorubicin—hematologic cancer	0.00601	0.0112	CbGbCtD
Levothyroxine—ABCB1—Alitretinoin—hematologic cancer	0.00588	0.011	CbGbCtD
Levothyroxine—ALB—Prednisone—hematologic cancer	0.00579	0.0108	CbGbCtD
Levothyroxine—CYP3A4—Lomustine—hematologic cancer	0.00571	0.0106	CbGbCtD
Levothyroxine—CYP3A4—Busulfan—hematologic cancer	0.00571	0.0106	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—hematologic cancer	0.00563	0.0105	CbGbCtD
Levothyroxine—ALB—Irinotecan—hematologic cancer	0.00549	0.0102	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—hematologic cancer	0.00531	0.00988	CbGbCtD
Levothyroxine—CYP3A4—Thiotepa—hematologic cancer	0.00509	0.00947	CbGbCtD
Levothyroxine—ABCB1—Imatinib—hematologic cancer	0.0046	0.00856	CbGbCtD
Levothyroxine—ABCB1—Nilotinib—hematologic cancer	0.00418	0.00778	CbGbCtD
Levothyroxine—ABCB1—Vinorelbine—hematologic cancer	0.00415	0.00772	CbGbCtD
Levothyroxine—CYP3A4—Methoxsalen—hematologic cancer	0.00395	0.00736	CbGbCtD
Levothyroxine—CYP3A4—Bortezomib—hematologic cancer	0.00376	0.007	CbGbCtD
Levothyroxine—ABCB1—Dasatinib—hematologic cancer	0.00369	0.00688	CbGbCtD
Levothyroxine—ABCB1—Mitoxantrone—hematologic cancer	0.00365	0.00679	CbGbCtD
Levothyroxine—CYP3A4—Daunorubicin—hematologic cancer	0.0036	0.0067	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—hematologic cancer	0.0034	0.00633	CbGbCtD
Levothyroxine—ABCB1—Betamethasone—hematologic cancer	0.00325	0.00605	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—hematologic cancer	0.00322	0.006	CbGbCtD
Levothyroxine—ABCB1—Prednisolone—hematologic cancer	0.00321	0.00597	CbGbCtD
Levothyroxine—SERPINA7—hematopoietic system—hematologic cancer	0.00321	0.0664	CbGeAlD
Levothyroxine—CYP3A4—Cytarabine—hematologic cancer	0.00317	0.00591	CbGbCtD
Levothyroxine—CYP3A4—Teniposide—hematologic cancer	0.00313	0.00582	CbGbCtD
Levothyroxine—ABCB1—Prednisone—hematologic cancer	0.00303	0.00564	CbGbCtD
Levothyroxine—ALB—Methotrexate—hematologic cancer	0.00291	0.00541	CbGbCtD
Levothyroxine—CYP3A4—Ifosfamide—hematologic cancer	0.00289	0.00537	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—hematologic cancer	0.00287	0.00535	CbGbCtD
Levothyroxine—CYP2C8—Dexamethasone—hematologic cancer	0.0028	0.0052	CbGbCtD
Levothyroxine—CYP3A4—Imatinib—hematologic cancer	0.00276	0.00513	CbGbCtD
Levothyroxine—CYP3A4—Ruxolitinib—hematologic cancer	0.0026	0.00483	CbGbCtD
Levothyroxine—ABCB1—Vinblastine—hematologic cancer	0.00255	0.00476	CbGbCtD
Levothyroxine—ABCB1—Vincristine—hematologic cancer	0.00251	0.00467	CbGbCtD
Levothyroxine—CYP3A4—Nilotinib—hematologic cancer	0.0025	0.00466	CbGbCtD
Levothyroxine—CYP3A4—Vinorelbine—hematologic cancer	0.00248	0.00462	CbGbCtD
Levothyroxine—ABCB1—Cisplatin—hematologic cancer	0.00234	0.00436	CbGbCtD
Levothyroxine—ABCB1—Etoposide—hematologic cancer	0.0023	0.00428	CbGbCtD
Levothyroxine—CYP3A4—Triamcinolone—hematologic cancer	0.00227	0.00423	CbGbCtD
Levothyroxine—CYP3A4—Dasatinib—hematologic cancer	0.00221	0.00412	CbGbCtD
Levothyroxine—CYP3A4—Mitoxantrone—hematologic cancer	0.00219	0.00407	CbGbCtD
Levothyroxine—SERPINA7—blood—hematologic cancer	0.00213	0.044	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—hematologic cancer	0.00206	0.0426	CbGeAlD
Levothyroxine—CYP3A4—Betamethasone—hematologic cancer	0.00195	0.00363	CbGbCtD
Levothyroxine—CYP3A4—Prednisolone—hematologic cancer	0.00192	0.00358	CbGbCtD
Levothyroxine—ABCB1—Dexamethasone—hematologic cancer	0.00189	0.00352	CbGbCtD
Levothyroxine—CYP3A4—Prednisone—hematologic cancer	0.00182	0.00338	CbGbCtD
Levothyroxine—CYP3A4—Irinotecan—hematologic cancer	0.00172	0.0032	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—hematologic cancer	0.00157	0.00292	CbGbCtD
Levothyroxine—CYP3A4—Vinblastine—hematologic cancer	0.00153	0.00285	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—hematologic cancer	0.00152	0.00283	CbGbCtD
Levothyroxine—SLC7A5—hematopoietic system—hematologic cancer	0.00151	0.0313	CbGeAlD
Levothyroxine—THRB—gonad—hematologic cancer	0.00151	0.0312	CbGeAlD
Levothyroxine—THRA—gonad—hematologic cancer	0.00151	0.0312	CbGeAlD
Levothyroxine—CYP3A4—Vincristine—hematologic cancer	0.0015	0.0028	CbGbCtD
Levothyroxine—TTR—hematopoietic system—hematologic cancer	0.00147	0.0305	CbGeAlD
Levothyroxine—CYP3A4—Etoposide—hematologic cancer	0.00138	0.00257	CbGbCtD
Levothyroxine—SLCO4C1—blood—hematologic cancer	0.00137	0.0283	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—hematologic cancer	0.00133	0.0274	CbGeAlD
Levothyroxine—SLCO4C1—lung—hematologic cancer	0.0012	0.0248	CbGeAlD
Levothyroxine—SLCO1B3—lung—hematologic cancer	0.00117	0.0241	CbGeAlD
Levothyroxine—SLCO1B1—hematopoietic system—hematologic cancer	0.00116	0.024	CbGeAlD
Levothyroxine—THRB—lung—hematologic cancer	0.00115	0.0238	CbGeAlD
Levothyroxine—THRA—lung—hematologic cancer	0.00115	0.0238	CbGeAlD
Levothyroxine—SLC7A5—gonad—hematologic cancer	0.00115	0.0238	CbGeAlD
Levothyroxine—CYP3A4—Dexamethasone—hematologic cancer	0.00113	0.00211	CbGbCtD
Levothyroxine—THRB—testis—hematologic cancer	0.00109	0.0225	CbGeAlD
Levothyroxine—THRA—testis—hematologic cancer	0.00109	0.0225	CbGeAlD
Levothyroxine—SLC16A2—lung—hematologic cancer	0.00104	0.0216	CbGeAlD
Levothyroxine—SLC7A5—blood—hematologic cancer	0.001	0.0207	CbGeAlD
Levothyroxine—SLC16A2—testis—hematologic cancer	0.000984	0.0204	CbGeAlD
Levothyroxine—TTR—blood—hematologic cancer	0.000976	0.0202	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—hematologic cancer	0.000969	0.0201	CbGeAlD
Levothyroxine—SLC7A5—Tretinoin—Alitretinoin—hematologic cancer	0.000962	0.376	CbGdCrCtD
Levothyroxine—SLC7A5—Isotretinoin—Alitretinoin—hematologic cancer	0.000962	0.376	CbGdCrCtD
Levothyroxine—SLCO1A2—hematopoietic system—hematologic cancer	0.000945	0.0196	CbGeAlD
Levothyroxine—TTR—bone marrow—hematologic cancer	0.000944	0.0195	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—hematologic cancer	0.00094	0.00175	CbGbCtD
Levothyroxine—SLCO1C1—testis—hematologic cancer	0.000903	0.0187	CbGeAlD
Levothyroxine—SLC7A5—lung—hematologic cancer	0.000878	0.0182	CbGeAlD
Levothyroxine—TTR—lung—hematologic cancer	0.000855	0.0177	CbGeAlD
Levothyroxine—SLC7A5—testis—hematologic cancer	0.000829	0.0172	CbGeAlD
Levothyroxine—TTR—testis—hematologic cancer	0.000807	0.0167	CbGeAlD
Levothyroxine—THRB—lymph node—hematologic cancer	0.000787	0.0163	CbGeAlD
Levothyroxine—THRA—lymph node—hematologic cancer	0.000787	0.0163	CbGeAlD
Levothyroxine—SLCO1B1—blood—hematologic cancer	0.00077	0.0159	CbGeAlD
Levothyroxine—SLCO4A1—lung—hematologic cancer	0.000767	0.0159	CbGeAlD
Levothyroxine—SLCO4A1—testis—hematologic cancer	0.000724	0.015	CbGeAlD
Levothyroxine—SLC16A2—lymph node—hematologic cancer	0.000713	0.0148	CbGeAlD
Levothyroxine—CYP2C8—hematopoietic system—hematologic cancer	0.000661	0.0137	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—hematologic cancer	0.000654	0.0135	CbGeAlD
Levothyroxine—SLC7A5—lymph node—hematologic cancer	0.000601	0.0124	CbGeAlD
Levothyroxine—SLCO1A2—lung—hematologic cancer	0.000549	0.0114	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—hematologic cancer	0.000524	0.0109	CbGeAlD
Levothyroxine—SLCO1A2—testis—hematologic cancer	0.000518	0.0107	CbGeAlD
Levothyroxine—ALB—testis—hematologic cancer	0.000515	0.0107	CbGeAlD
Levothyroxine—CYP3A4—hematopoietic system—hematologic cancer	0.000447	0.00926	CbGeAlD
Levothyroxine—CYP2C8—blood—hematologic cancer	0.000438	0.00906	CbGeAlD
Levothyroxine—ALB—lymph node—hematologic cancer	0.000373	0.00773	CbGeAlD
Levothyroxine—CYP2C8—testis—hematologic cancer	0.000362	0.00749	CbGeAlD
Levothyroxine—ABCB1—hematopoietic system—hematologic cancer	0.000317	0.00656	CbGeAlD
Levothyroxine—CYP3A4—blood—hematologic cancer	0.000296	0.00614	CbGeAlD
Levothyroxine—ABCB1—gonad—hematologic cancer	0.000241	0.00498	CbGeAlD
Levothyroxine—ABCB1—blood—hematologic cancer	0.00021	0.00434	CbGeAlD
Levothyroxine—ABCB1—bone marrow—hematologic cancer	0.000203	0.0042	CbGeAlD
Levothyroxine—ABCB1—lung—hematologic cancer	0.000184	0.00381	CbGeAlD
Levothyroxine—ABCB1—testis—hematologic cancer	0.000174	0.00359	CbGeAlD
Levothyroxine—Liotrix—ALB—hematologic cancer	0.00017	0.296	CrCbGaD
Levothyroxine—Liotrix—ABCB1—hematologic cancer	0.000162	0.282	CrCbGaD
Levothyroxine—SLC7A5—Desoximetasone—Betamethasone—hematologic cancer	0.000131	0.0514	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Dexamethasone—hematologic cancer	0.000131	0.0514	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Triamcinolone—hematologic cancer	0.000128	0.0502	CbGdCrCtD
Levothyroxine—ABCB1—lymph node—hematologic cancer	0.000126	0.0026	CbGeAlD
Levothyroxine—Liothyronine—ALB—hematologic cancer	0.000124	0.216	CrCbGaD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—hematologic cancer	0.000122	0.0477	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisolone—hematologic cancer	0.000119	0.0465	CbGdCrCtD
Levothyroxine—Liothyronine—ABCB1—hematologic cancer	0.000118	0.206	CrCbGaD
Levothyroxine—Nausea—Bleomycin—hematologic cancer	5.2e-05	0.000314	CcSEcCtD
Levothyroxine—Rash—Thiotepa—hematologic cancer	5.19e-05	0.000313	CcSEcCtD
Levothyroxine—Dermatitis—Thiotepa—hematologic cancer	5.19e-05	0.000313	CcSEcCtD
Levothyroxine—Hyperhidrosis—Triamcinolone—hematologic cancer	5.18e-05	0.000313	CcSEcCtD
Levothyroxine—Diarrhoea—Alitretinoin—hematologic cancer	5.18e-05	0.000313	CcSEcCtD
Levothyroxine—Convulsion—Betamethasone—hematologic cancer	5.17e-05	0.000312	CcSEcCtD
Levothyroxine—Convulsion—Dexamethasone—hematologic cancer	5.17e-05	0.000312	CcSEcCtD
Levothyroxine—Headache—Thiotepa—hematologic cancer	5.16e-05	0.000311	CcSEcCtD
Levothyroxine—Diarrhoea—Ifosfamide—hematologic cancer	5.12e-05	0.000309	CcSEcCtD
Levothyroxine—Nausea—Vinorelbine—hematologic cancer	5.12e-05	0.000309	CcSEcCtD
Levothyroxine—Body temperature increased—Cisplatin—hematologic cancer	5.1e-05	0.000308	CcSEcCtD
Levothyroxine—Asthenia—Mitoxantrone—hematologic cancer	5.1e-05	0.000308	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—hematologic cancer	5.1e-05	0.000308	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—hematologic cancer	5.1e-05	0.000308	CcSEcCtD
Levothyroxine—Vomiting—Thalidomide—hematologic cancer	5.06e-05	0.000306	CcSEcCtD
Levothyroxine—Anxiety—Betamethasone—hematologic cancer	5.06e-05	0.000305	CcSEcCtD
Levothyroxine—Anxiety—Dexamethasone—hematologic cancer	5.06e-05	0.000305	CcSEcCtD
Levothyroxine—Rash—Thalidomide—hematologic cancer	5.02e-05	0.000303	CcSEcCtD
Levothyroxine—Dermatitis—Thalidomide—hematologic cancer	5.02e-05	0.000303	CcSEcCtD
Levothyroxine—Diarrhoea—Vincristine—hematologic cancer	4.99e-05	0.000302	CcSEcCtD
Levothyroxine—Headache—Thalidomide—hematologic cancer	4.99e-05	0.000301	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—hematologic cancer	4.98e-05	0.000301	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—hematologic cancer	4.97e-05	0.0003	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—hematologic cancer	4.9e-05	0.000296	CcSEcCtD
Levothyroxine—Nausea—Thiotepa—hematologic cancer	4.89e-05	0.000295	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	4.89e-05	0.000295	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—hematologic cancer	4.88e-05	0.000295	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—hematologic cancer	4.87e-05	0.000294	CcSEcCtD
Levothyroxine—Diarrhoea—Irinotecan—hematologic cancer	4.86e-05	0.000294	CcSEcCtD
Levothyroxine—Diarrhoea—Mitoxantrone—hematologic cancer	4.86e-05	0.000294	CcSEcCtD
Levothyroxine—Vomiting—Carmustine—hematologic cancer	4.86e-05	0.000293	CcSEcCtD
Levothyroxine—Insomnia—Triamcinolone—hematologic cancer	4.85e-05	0.000293	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—hematologic cancer	4.84e-05	0.000292	CcSEcCtD
Levothyroxine—Rash—Carmustine—hematologic cancer	4.82e-05	0.000291	CcSEcCtD
Levothyroxine—Dermatitis—Carmustine—hematologic cancer	4.82e-05	0.000291	CcSEcCtD
Levothyroxine—Vomiting—Alitretinoin—hematologic cancer	4.82e-05	0.000291	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisolone—hematologic cancer	4.81e-05	0.00029	CcSEcCtD
Levothyroxine—Headache—Carmustine—hematologic cancer	4.79e-05	0.000289	CcSEcCtD
Levothyroxine—Shock—Betamethasone—hematologic cancer	4.79e-05	0.000289	CcSEcCtD
Levothyroxine—Shock—Dexamethasone—hematologic cancer	4.79e-05	0.000289	CcSEcCtD
Levothyroxine—Dyspnoea—Triamcinolone—hematologic cancer	4.78e-05	0.000289	CcSEcCtD
Levothyroxine—Rash—Alitretinoin—hematologic cancer	4.78e-05	0.000288	CcSEcCtD
Levothyroxine—Agitation—Prednisone—hematologic cancer	4.77e-05	0.000288	CcSEcCtD
Levothyroxine—Dermatitis—Alitretinoin—hematologic cancer	4.77e-05	0.000288	CcSEcCtD
Levothyroxine—Vomiting—Ifosfamide—hematologic cancer	4.76e-05	0.000287	CcSEcCtD
Levothyroxine—Tachycardia—Dexamethasone—hematologic cancer	4.75e-05	0.000287	CcSEcCtD
Levothyroxine—Tachycardia—Betamethasone—hematologic cancer	4.75e-05	0.000287	CcSEcCtD
Levothyroxine—Headache—Alitretinoin—hematologic cancer	4.75e-05	0.000286	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—hematologic cancer	4.74e-05	0.000286	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—hematologic cancer	4.74e-05	0.000286	CcSEcCtD
Levothyroxine—Nausea—Thalidomide—hematologic cancer	4.73e-05	0.000285	CcSEcCtD
Levothyroxine—Rash—Ifosfamide—hematologic cancer	4.72e-05	0.000285	CcSEcCtD
Levothyroxine—Dermatitis—Ifosfamide—hematologic cancer	4.72e-05	0.000285	CcSEcCtD
Levothyroxine—Hyperhidrosis—Betamethasone—hematologic cancer	4.7e-05	0.000284	CcSEcCtD
Levothyroxine—Hyperhidrosis—Dexamethasone—hematologic cancer	4.7e-05	0.000284	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—hematologic cancer	4.7e-05	0.000284	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—hematologic cancer	4.67e-05	0.000282	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—hematologic cancer	4.67e-05	0.000282	CcSEcCtD
Levothyroxine—Vomiting—Vincristine—hematologic cancer	4.64e-05	0.00028	CcSEcCtD
Levothyroxine—Urticaria—Prednisolone—hematologic cancer	4.63e-05	0.00028	CcSEcCtD
Levothyroxine—Asthenia—Cisplatin—hematologic cancer	4.63e-05	0.00028	CcSEcCtD
Levothyroxine—Fatigue—Triamcinolone—hematologic cancer	4.62e-05	0.000279	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—hematologic cancer	4.61e-05	0.000278	CcSEcCtD
Levothyroxine—Rash—Vincristine—hematologic cancer	4.6e-05	0.000278	CcSEcCtD
Levothyroxine—Dermatitis—Vincristine—hematologic cancer	4.6e-05	0.000278	CcSEcCtD
Levothyroxine—Headache—Vincristine—hematologic cancer	4.57e-05	0.000276	CcSEcCtD
Levothyroxine—Nausea—Carmustine—hematologic cancer	4.54e-05	0.000274	CcSEcCtD
Levothyroxine—Vomiting—Mitoxantrone—hematologic cancer	4.52e-05	0.000273	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—hematologic cancer	4.52e-05	0.000273	CcSEcCtD
Levothyroxine—Nausea—Alitretinoin—hematologic cancer	4.5e-05	0.000272	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—hematologic cancer	4.5e-05	0.000272	CcSEcCtD
Levothyroxine—Rash—Mitoxantrone—hematologic cancer	4.48e-05	0.000271	CcSEcCtD
Levothyroxine—Rash—Irinotecan—hematologic cancer	4.48e-05	0.000271	CcSEcCtD
Levothyroxine—Dermatitis—Mitoxantrone—hematologic cancer	4.48e-05	0.00027	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—hematologic cancer	4.48e-05	0.00027	CcSEcCtD
Levothyroxine—Headache—Irinotecan—hematologic cancer	4.45e-05	0.000269	CcSEcCtD
Levothyroxine—Headache—Mitoxantrone—hematologic cancer	4.45e-05	0.000269	CcSEcCtD
Levothyroxine—Nausea—Ifosfamide—hematologic cancer	4.45e-05	0.000268	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.43e-05	0.000268	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.43e-05	0.000268	CcSEcCtD
Levothyroxine—Arthralgia—Prednisone—hematologic cancer	4.42e-05	0.000267	CcSEcCtD
Levothyroxine—Feeling abnormal—Triamcinolone—hematologic cancer	4.42e-05	0.000267	CcSEcCtD
Levothyroxine—Diarrhoea—Cisplatin—hematologic cancer	4.42e-05	0.000267	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—hematologic cancer	4.41e-05	0.000266	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—hematologic cancer	4.41e-05	0.000266	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—hematologic cancer	4.4e-05	0.000266	CcSEcCtD
Levothyroxine—Insomnia—Betamethasone—hematologic cancer	4.4e-05	0.000266	CcSEcCtD
Levothyroxine—Insomnia—Dexamethasone—hematologic cancer	4.4e-05	0.000266	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—hematologic cancer	4.37e-05	0.000264	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—hematologic cancer	4.36e-05	0.000263	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—hematologic cancer	4.34e-05	0.000262	CcSEcCtD
Levothyroxine—Nausea—Vincristine—hematologic cancer	4.34e-05	0.000262	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—hematologic cancer	4.33e-05	0.000261	CcSEcCtD
Levothyroxine—Urticaria—Triamcinolone—hematologic cancer	4.26e-05	0.000257	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—hematologic cancer	4.24e-05	0.000256	CcSEcCtD
Levothyroxine—Body temperature increased—Triamcinolone—hematologic cancer	4.24e-05	0.000256	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—hematologic cancer	4.22e-05	0.000255	CcSEcCtD
Levothyroxine—Nausea—Mitoxantrone—hematologic cancer	4.22e-05	0.000255	CcSEcCtD
Levothyroxine—Fatigue—Dexamethasone—hematologic cancer	4.2e-05	0.000253	CcSEcCtD
Levothyroxine—Fatigue—Betamethasone—hematologic cancer	4.2e-05	0.000253	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—hematologic cancer	4.18e-05	0.000253	CcSEcCtD
Levothyroxine—Shock—Prednisone—hematologic cancer	4.17e-05	0.000252	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—hematologic cancer	4.17e-05	0.000252	CcSEcCtD
Levothyroxine—Tachycardia—Prednisone—hematologic cancer	4.14e-05	0.00025	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—hematologic cancer	4.12e-05	0.000249	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—hematologic cancer	4.11e-05	0.000248	CcSEcCtD
Levothyroxine—Vomiting—Cisplatin—hematologic cancer	4.1e-05	0.000248	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisone—hematologic cancer	4.1e-05	0.000247	CcSEcCtD
Levothyroxine—Rash—Cisplatin—hematologic cancer	4.07e-05	0.000246	CcSEcCtD
Levothyroxine—Dermatitis—Cisplatin—hematologic cancer	4.07e-05	0.000245	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—hematologic cancer	4.05e-05	0.000244	CcSEcCtD
Levothyroxine—Feeling abnormal—Betamethasone—hematologic cancer	4.01e-05	0.000242	CcSEcCtD
Levothyroxine—Feeling abnormal—Dexamethasone—hematologic cancer	4.01e-05	0.000242	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—hematologic cancer	4.01e-05	0.000242	CcSEcCtD
Levothyroxine—Tension—Epirubicin—hematologic cancer	3.99e-05	0.000241	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.98e-05	0.00024	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.98e-05	0.00024	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—hematologic cancer	3.94e-05	0.000238	CcSEcCtD
Levothyroxine—Urticaria—Dexamethasone—hematologic cancer	3.87e-05	0.000233	CcSEcCtD
Levothyroxine—Urticaria—Betamethasone—hematologic cancer	3.87e-05	0.000233	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.86e-05	0.000233	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—hematologic cancer	3.86e-05	0.000233	CcSEcCtD
Levothyroxine—Asthenia—Triamcinolone—hematologic cancer	3.85e-05	0.000232	CcSEcCtD
Levothyroxine—Abdominal pain—Dexamethasone—hematologic cancer	3.85e-05	0.000232	CcSEcCtD
Levothyroxine—Body temperature increased—Dexamethasone—hematologic cancer	3.85e-05	0.000232	CcSEcCtD
Levothyroxine—Abdominal pain—Betamethasone—hematologic cancer	3.85e-05	0.000232	CcSEcCtD
Levothyroxine—Body temperature increased—Betamethasone—hematologic cancer	3.85e-05	0.000232	CcSEcCtD
Levothyroxine—Nausea—Cisplatin—hematologic cancer	3.83e-05	0.000231	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—hematologic cancer	3.83e-05	0.000231	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—hematologic cancer	3.81e-05	0.00023	CcSEcCtD
Levothyroxine—Pruritus—Triamcinolone—hematologic cancer	3.79e-05	0.000229	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—hematologic cancer	3.76e-05	0.000227	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—hematologic cancer	3.76e-05	0.000227	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—hematologic cancer	3.73e-05	0.000225	CcSEcCtD
Levothyroxine—Rash—Etoposide—hematologic cancer	3.73e-05	0.000225	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—hematologic cancer	3.72e-05	0.000225	CcSEcCtD
Levothyroxine—Headache—Etoposide—hematologic cancer	3.7e-05	0.000224	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—hematologic cancer	3.69e-05	0.000223	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—hematologic cancer	3.69e-05	0.000223	CcSEcCtD
Levothyroxine—Rash—Prednisolone—hematologic cancer	3.68e-05	0.000222	CcSEcCtD
Levothyroxine—Dermatitis—Prednisolone—hematologic cancer	3.67e-05	0.000222	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—hematologic cancer	3.65e-05	0.000221	CcSEcCtD
Levothyroxine—Headache—Prednisolone—hematologic cancer	3.65e-05	0.000221	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—hematologic cancer	3.65e-05	0.00022	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—hematologic cancer	3.59e-05	0.000217	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—hematologic cancer	3.57e-05	0.000216	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—hematologic cancer	3.52e-05	0.000212	CcSEcCtD
Levothyroxine—Nausea—Etoposide—hematologic cancer	3.51e-05	0.000212	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—hematologic cancer	3.49e-05	0.000211	CcSEcCtD
Levothyroxine—Asthenia—Betamethasone—hematologic cancer	3.49e-05	0.000211	CcSEcCtD
Levothyroxine—Asthenia—Dexamethasone—hematologic cancer	3.49e-05	0.000211	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—hematologic cancer	3.47e-05	0.000209	CcSEcCtD
Levothyroxine—Nausea—Prednisolone—hematologic cancer	3.46e-05	0.000209	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—hematologic cancer	3.46e-05	0.000209	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—hematologic cancer	3.45e-05	0.000208	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—hematologic cancer	3.45e-05	0.000208	CcSEcCtD
Levothyroxine—Pruritus—Dexamethasone—hematologic cancer	3.44e-05	0.000208	CcSEcCtD
Levothyroxine—Pruritus—Betamethasone—hematologic cancer	3.44e-05	0.000208	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—hematologic cancer	3.42e-05	0.000207	CcSEcCtD
Levothyroxine—Vomiting—Triamcinolone—hematologic cancer	3.41e-05	0.000206	CcSEcCtD
Levothyroxine—Rash—Triamcinolone—hematologic cancer	3.38e-05	0.000204	CcSEcCtD
Levothyroxine—Dermatitis—Triamcinolone—hematologic cancer	3.38e-05	0.000204	CcSEcCtD
Levothyroxine—Urticaria—Prednisone—hematologic cancer	3.37e-05	0.000203	CcSEcCtD
Levothyroxine—Headache—Triamcinolone—hematologic cancer	3.36e-05	0.000203	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—hematologic cancer	3.35e-05	0.000202	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—hematologic cancer	3.35e-05	0.000202	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—hematologic cancer	3.34e-05	0.000202	CcSEcCtD
Levothyroxine—Diarrhoea—Betamethasone—hematologic cancer	3.33e-05	0.000201	CcSEcCtD
Levothyroxine—Diarrhoea—Dexamethasone—hematologic cancer	3.33e-05	0.000201	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—hematologic cancer	3.32e-05	0.0002	CcSEcCtD
Levothyroxine—Shock—Epirubicin—hematologic cancer	3.26e-05	0.000197	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—hematologic cancer	3.26e-05	0.000197	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—hematologic cancer	3.23e-05	0.000195	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.23e-05	0.000195	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—hematologic cancer	3.2e-05	0.000193	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—hematologic cancer	3.2e-05	0.000193	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—hematologic cancer	3.2e-05	0.000193	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—hematologic cancer	3.19e-05	0.000192	CcSEcCtD
Levothyroxine—Nausea—Triamcinolone—hematologic cancer	3.19e-05	0.000192	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—hematologic cancer	3.16e-05	0.000191	CcSEcCtD
Levothyroxine—Vomiting—Betamethasone—hematologic cancer	3.09e-05	0.000187	CcSEcCtD
Levothyroxine—Vomiting—Dexamethasone—hematologic cancer	3.09e-05	0.000187	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—hematologic cancer	3.09e-05	0.000187	CcSEcCtD
Levothyroxine—Rash—Dexamethasone—hematologic cancer	3.07e-05	0.000185	CcSEcCtD
Levothyroxine—Rash—Betamethasone—hematologic cancer	3.07e-05	0.000185	CcSEcCtD
Levothyroxine—Dermatitis—Dexamethasone—hematologic cancer	3.07e-05	0.000185	CcSEcCtD
Levothyroxine—Dermatitis—Betamethasone—hematologic cancer	3.07e-05	0.000185	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—hematologic cancer	3.05e-05	0.000184	CcSEcCtD
Levothyroxine—Headache—Dexamethasone—hematologic cancer	3.05e-05	0.000184	CcSEcCtD
Levothyroxine—Headache—Betamethasone—hematologic cancer	3.05e-05	0.000184	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—hematologic cancer	3.04e-05	0.000184	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.02e-05	0.000182	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—hematologic cancer	3.02e-05	0.000182	CcSEcCtD
Levothyroxine—Pruritus—Prednisone—hematologic cancer	3e-05	0.000181	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—hematologic cancer	3e-05	0.000181	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—hematologic cancer	2.99e-05	0.000181	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.96e-05	0.000179	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—hematologic cancer	2.96e-05	0.000178	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—hematologic cancer	2.92e-05	0.000176	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—hematologic cancer	2.9e-05	0.000175	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.9e-05	0.000175	CcSEcCtD
Levothyroxine—Nausea—Betamethasone—hematologic cancer	2.89e-05	0.000174	CcSEcCtD
Levothyroxine—Nausea—Dexamethasone—hematologic cancer	2.89e-05	0.000174	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—hematologic cancer	2.86e-05	0.000173	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—hematologic cancer	2.81e-05	0.00017	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—hematologic cancer	2.8e-05	0.000169	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—hematologic cancer	2.8e-05	0.000169	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.79e-05	0.000169	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—hematologic cancer	2.77e-05	0.000167	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—hematologic cancer	2.73e-05	0.000165	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—hematologic cancer	2.73e-05	0.000165	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.71e-05	0.000164	CcSEcCtD
Levothyroxine—Vomiting—Prednisone—hematologic cancer	2.69e-05	0.000163	CcSEcCtD
Levothyroxine—Rash—Prednisone—hematologic cancer	2.67e-05	0.000161	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—hematologic cancer	2.67e-05	0.000161	CcSEcCtD
Levothyroxine—Headache—Prednisone—hematologic cancer	2.65e-05	0.00016	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—hematologic cancer	2.64e-05	0.00016	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—hematologic cancer	2.63e-05	0.000159	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—hematologic cancer	2.62e-05	0.000158	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—hematologic cancer	2.62e-05	0.000158	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—hematologic cancer	2.54e-05	0.000153	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—hematologic cancer	2.53e-05	0.000153	CcSEcCtD
Levothyroxine—Nausea—Prednisone—hematologic cancer	2.52e-05	0.000152	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.51e-05	0.000151	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—hematologic cancer	2.51e-05	0.000151	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—hematologic cancer	2.44e-05	0.000147	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—hematologic cancer	2.42e-05	0.000146	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—hematologic cancer	2.42e-05	0.000146	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—hematologic cancer	2.42e-05	0.000146	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—hematologic cancer	2.38e-05	0.000144	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—hematologic cancer	2.35e-05	0.000142	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—hematologic cancer	2.27e-05	0.000137	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—hematologic cancer	2.25e-05	0.000136	CcSEcCtD
Levothyroxine—Rash—Methotrexate—hematologic cancer	2.23e-05	0.000135	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—hematologic cancer	2.23e-05	0.000135	CcSEcCtD
Levothyroxine—Headache—Methotrexate—hematologic cancer	2.22e-05	0.000134	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—hematologic cancer	2.2e-05	0.000133	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—hematologic cancer	2.17e-05	0.000131	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—hematologic cancer	2.11e-05	0.000127	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—hematologic cancer	2.1e-05	0.000127	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—hematologic cancer	2.1e-05	0.000127	CcSEcCtD
Levothyroxine—Rash—Epirubicin—hematologic cancer	2.09e-05	0.000126	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—hematologic cancer	2.09e-05	0.000126	CcSEcCtD
Levothyroxine—Headache—Epirubicin—hematologic cancer	2.08e-05	0.000125	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—hematologic cancer	1.97e-05	0.000119	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—hematologic cancer	1.95e-05	0.000118	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—hematologic cancer	1.93e-05	0.000117	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—hematologic cancer	1.93e-05	0.000117	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—hematologic cancer	1.92e-05	0.000116	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—hematologic cancer	1.82e-05	0.00011	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—CASP3—hematologic cancer	4.77e-06	5.23e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL2—hematologic cancer	4.77e-06	5.22e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—hematologic cancer	4.75e-06	5.21e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CDA—hematologic cancer	4.73e-06	5.19e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALOX5—hematologic cancer	4.71e-06	5.16e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MTHFR—hematologic cancer	4.69e-06	5.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ALOX5—hematologic cancer	4.68e-06	5.13e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ABCB1—hematologic cancer	4.67e-06	5.12e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PTPN11—hematologic cancer	4.67e-06	5.11e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—IDH1—hematologic cancer	4.65e-06	5.1e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CREBBP—hematologic cancer	4.65e-06	5.1e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.65e-06	5.1e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—hematologic cancer	4.65e-06	5.09e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—JUN—hematologic cancer	4.64e-06	5.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.61e-06	5.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCC3—hematologic cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTO1—hematologic cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TXN—hematologic cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NUP98—hematologic cancer	4.56e-06	5e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PC—hematologic cancer	4.55e-06	4.99e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	4.54e-06	4.98e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	4.54e-06	4.98e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NUP98—hematologic cancer	4.53e-06	4.97e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—hematologic cancer	4.52e-06	4.95e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SPHK1—hematologic cancer	4.5e-06	4.93e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—hematologic cancer	4.49e-06	4.93e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—hematologic cancer	4.48e-06	4.92e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ADCY7—hematologic cancer	4.42e-06	4.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA3—hematologic cancer	4.42e-06	4.85e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	4.41e-06	4.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CREBBP—hematologic cancer	4.4e-06	4.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ADCY7—hematologic cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA3—hematologic cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GBA—hematologic cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NUP214—hematologic cancer	4.39e-06	4.82e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK8—hematologic cancer	4.39e-06	4.81e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NUP214—hematologic cancer	4.37e-06	4.79e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—hematologic cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.32e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.32e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCG2—hematologic cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTR—hematologic cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.3e-06	4.72e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCG2—hematologic cancer	4.28e-06	4.69e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTR—hematologic cancer	4.28e-06	4.69e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—hematologic cancer	4.28e-06	4.69e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.24e-06	4.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO2—hematologic cancer	4.22e-06	4.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CRABP1—hematologic cancer	4.21e-06	4.61e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.21e-06	4.61e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO2—hematologic cancer	4.2e-06	4.6e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—hematologic cancer	4.18e-06	4.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CD—hematologic cancer	4.17e-06	4.58e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	4.16e-06	4.56e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SRC—hematologic cancer	4.16e-06	4.56e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.13e-06	4.53e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALOX5—hematologic cancer	4.1e-06	4.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.1e-06	4.49e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—hematologic cancer	4.09e-06	4.49e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—hematologic cancer	4.07e-06	4.46e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—hematologic cancer	4.05e-06	4.44e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.03e-06	4.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTAP—hematologic cancer	4.02e-06	4.41e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	4.01e-06	4.4e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—hematologic cancer	4.01e-06	4.4e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.01e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SDC1—hematologic cancer	4e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—hematologic cancer	4e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—hematologic cancer	4e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SDC1—hematologic cancer	3.98e-06	4.36e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NUP98—hematologic cancer	3.97e-06	4.35e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3R1—hematologic cancer	3.94e-06	4.32e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	3.94e-06	4.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ADCY7—hematologic cancer	3.85e-06	4.23e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA3—hematologic cancer	3.85e-06	4.23e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	3.84e-06	4.21e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—hematologic cancer	3.83e-06	4.2e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—JAK2—hematologic cancer	3.83e-06	4.2e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NUP214—hematologic cancer	3.83e-06	4.2e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.82e-06	4.19e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.81e-06	4.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.8e-06	4.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.77e-06	4.14e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTR—hematologic cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCG2—hematologic cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—hematologic cancer	3.73e-06	4.09e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—hematologic cancer	3.72e-06	4.08e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—hematologic cancer	3.69e-06	4.05e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO2—hematologic cancer	3.68e-06	4.03e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CREBBP—hematologic cancer	3.65e-06	4.01e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—hematologic cancer	3.64e-06	3.99e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.61e-06	3.96e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.59e-06	3.93e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—FHL2—hematologic cancer	3.58e-06	3.93e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—hematologic cancer	3.57e-06	3.91e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.53e-06	3.87e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AGRN—hematologic cancer	3.52e-06	3.85e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.52e-06	3.85e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SDC1—hematologic cancer	3.49e-06	3.82e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	3.46e-06	3.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.46e-06	3.79e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—hematologic cancer	3.44e-06	3.78e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—hematologic cancer	3.42e-06	3.75e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD44—hematologic cancer	3.4e-06	3.73e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NQO1—hematologic cancer	3.4e-06	3.73e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD44—hematologic cancer	3.38e-06	3.71e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NQO1—hematologic cancer	3.38e-06	3.71e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	3.37e-06	3.69e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—hematologic cancer	3.34e-06	3.66e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.34e-06	3.66e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.33e-06	3.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.33e-06	3.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.33e-06	3.65e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—hematologic cancer	3.32e-06	3.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.31e-06	3.63e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	3.27e-06	3.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYCS—hematologic cancer	3.22e-06	3.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYCS—hematologic cancer	3.2e-06	3.51e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.2e-06	3.51e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HSP90AA1—hematologic cancer	3.18e-06	3.49e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—hematologic cancer	3.17e-06	3.47e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—hematologic cancer	3.16e-06	3.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.13e-06	3.44e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.13e-06	3.43e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.12e-06	3.43e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—hematologic cancer	3.06e-06	3.36e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA9—hematologic cancer	3.05e-06	3.34e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.05e-06	3.34e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	3.02e-06	3.31e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.01e-06	3.3e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—hematologic cancer	3e-06	3.29e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NQO1—hematologic cancer	2.96e-06	3.25e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD44—hematologic cancer	2.96e-06	3.25e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.96e-06	3.25e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—hematologic cancer	2.93e-06	3.21e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—hematologic cancer	2.92e-06	3.21e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—hematologic cancer	2.92e-06	3.2e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.88e-06	3.16e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—IDH1—hematologic cancer	2.87e-06	3.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.86e-06	3.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—hematologic cancer	2.84e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.84e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.83e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.83e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TXN—hematologic cancer	2.83e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—hematologic cancer	2.82e-06	3.09e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—hematologic cancer	2.8e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYCS—hematologic cancer	2.8e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—hematologic cancer	2.8e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.8e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.79e-06	3.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.77e-06	3.04e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.75e-06	3.01e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.73e-06	2.99e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—hematologic cancer	2.69e-06	2.95e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.69e-06	2.94e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—hematologic cancer	2.67e-06	2.93e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.66e-06	2.92e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.61e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.61e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.61e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—hematologic cancer	2.61e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—hematologic cancer	2.59e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOR1—hematologic cancer	2.59e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.59e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.59e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—hematologic cancer	2.58e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.58e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.53e-06	2.77e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—hematologic cancer	2.49e-06	2.73e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.47e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.45e-06	2.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—hematologic cancer	2.41e-06	2.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.37e-06	2.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.37e-06	2.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.36e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.34e-06	2.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTR—hematologic cancer	2.31e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.31e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.3e-06	2.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—hematologic cancer	2.29e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.27e-06	2.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.27e-06	2.49e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.23e-06	2.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—hematologic cancer	2.22e-06	2.43e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.2e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.15e-06	2.35e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—hematologic cancer	2.15e-06	2.35e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—hematologic cancer	2.13e-06	2.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—hematologic cancer	2.05e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.03e-06	2.23e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.02e-06	2.21e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.01e-06	2.2e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.94e-06	2.12e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—hematologic cancer	1.93e-06	2.11e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.91e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.84e-06	2.02e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.83e-06	2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD44—hematologic cancer	1.83e-06	2e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—hematologic cancer	1.81e-06	1.99e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.8e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CREBBP—hematologic cancer	1.78e-06	1.96e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.73e-06	1.89e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.72e-06	1.88e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.7e-06	1.87e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—hematologic cancer	1.69e-06	1.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.69e-06	1.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—hematologic cancer	1.68e-06	1.84e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.61e-06	1.76e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3R1—hematologic cancer	1.6e-06	1.75e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.57e-06	1.73e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.56e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.52e-06	1.67e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.5e-06	1.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.48e-06	1.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.48e-06	1.63e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—hematologic cancer	1.48e-06	1.62e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—hematologic cancer	1.46e-06	1.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.44e-06	1.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.4e-06	1.54e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.4e-06	1.53e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.4e-06	1.53e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.29e-06	1.42e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.29e-06	1.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.28e-06	1.41e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—hematologic cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—hematologic cancer	1.22e-06	1.34e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—hematologic cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—hematologic cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—hematologic cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.64e-07	1.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.14e-07	1e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.04e-07	9.92e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—hematologic cancer	9.02e-07	9.89e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—hematologic cancer	8.99e-07	9.86e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.63e-07	9.46e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.96e-07	8.73e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.88e-07	8.64e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—hematologic cancer	7.39e-07	8.1e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—hematologic cancer	7.35e-07	8.05e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.88e-07	7.54e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—hematologic cancer	6.56e-07	7.19e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—hematologic cancer	6.44e-07	7.06e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.85e-07	5.32e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.97e-07	4.35e-06	CbGpPWpGaD
